OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹17 Cr | ₹11 Cr | ₹6.33 Cr | ₹8.67 Cr | ₹3.19 Cr |
What is the latest Cash Flow from Financing Activities ratio of OXYGENTA PHARMACEUTICAL ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹17 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹6.33 Cr |
Mar2021 | ₹8.67 Cr |
Mar2020 | ₹3.19 Cr |
How is Cash Flow from Financing Activities of OXYGENTA PHARMACEUTICAL Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹17 Cr | 52.64 | |
Mar2023 | ₹11 Cr | 77.26 | |
Mar2022 | ₹6.33 Cr | -26.94 | |
Mar2021 | ₹8.67 Cr | 171.78 | |
Mar2020 | ₹3.19 Cr | - |
Compare Cash Flow from Financing Activities of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹460.3 Cr | 26.6% | 50.5% | 202.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | 26.6% |
50.5% |
202.1% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses